Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

GWPH / GW Pharmaceuticals Plc. / Capital World Investors - SC 13G (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this co

GWPH / GW Pharmaceuticals Plc. / Capital World Investors - SC 13G (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this co

GWPH / GW Pharmaceuticals Plc. / SCOPIA CAPITAL MANAGEMENT LP - SCHEDULE 13G/A (Passive Investment)

2018-02-15 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 2)*     GW Pharmaceuticals PLC (Name of Issuer)     American Depositary Shares, each representing 12 Ordinary Shares, par value £0.001 per share (Title of Class of Securities)     36197T103 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which t

GWPH / GW Pharmaceuticals Plc. FORM 6-K (Current Report of Foreign Issuer)

2018-02-15 sec.gov
    United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Form 6-K     REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934   For the Month of February, 2018   Commission File Number: 001-35892      GW PHARMACEUTICALS PLC (Translation of registrant’s name into English)   Sovereign House Vision Park Histon Cambridge CB24 9BZ United Kingdom (Address of principal executive offices)     Indicate by check mark whether the regi

GWPH / GW Pharmaceuticals Plc. / SCOPIA CAPITAL MANAGEMENT LP - SCHEDULE 13G/A (Passive Investment)

2018-02-15 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 2)*     GW Pharmaceuticals PLC (Name of Issuer)     American Depositary Shares, each representing 12 Ordinary Shares, par value £0.001 per share (Title of Class of Securities)     36197T103 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which t

GWPH / GW Pharmaceuticals Plc. / M&G INVESTMENT MANAGEMENT LTD - GW PHARMACEUTICALS PLC (Passive Investment)

2018-02-14 sec.gov
GW Pharmaceuticals Plc UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* GW Pharmaceuticals Plc         (Name of Issuer)   American Depositary Receipt         (Title of Class of Securities)   36197T103         (CUSIP Number)     31st December 2017           (Date of Event Which Requires Filing of this Statement)    Check the appropriate box to designate the rule pursuant to which this Schedule is file

GWPH / GW Pharmaceuticals Plc. / M&G INVESTMENT MANAGEMENT LTD - GW PHARMACEUTICALS PLC (Passive Investment)

2018-02-14 sec.gov
GW Pharmaceuticals Plc UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* GW Pharmaceuticals Plc         (Name of Issuer)   American Depositary Receipt         (Title of Class of Securities)   36197T103         (CUSIP Number)     31st December 2017           (Date of Event Which Requires Filing of this Statement)    Check the appropriate box to designate the rule pursuant to which this Schedule is file

GWPH / GW Pharmaceuticals Plc. / Capital Research Global Investors - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this c

GWPH / GW Pharmaceuticals Plc. / Capital Research Global Investors - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this c

GWPH / GW Pharmaceuticals Plc. / SMALLCAP WORLD FUND INC - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this c

GWPH / GW Pharmaceuticals Plc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-14 fintel.io
GW Pharmaceuticals Plc. (NASDAQ:GWPH) has 198 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55,649,729 shares. Largest shareholders include Smallcap World Fund Inc, FMR LLC / Fidelity, Capital Research Global Investors, Scopia Capital Management Lp, Prudential Plc, Price T Rowe Associates Inc /md/, Henderson Group Plc, BlackRock Inc. (34-0)

GWPH / GW Pharmaceuticals Plc. / SMALLCAP WORLD FUND INC - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* GW Pharmaceuticals plc (Name of Issuer) Ordinary Shares (Title of Class of Securities) 36197T103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this c

GWPH / GW Pharmaceuticals Plc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 3 GW PHARMACEUTICALS PLC COMMON STOCK Cusip #G4210C104 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #G4210C104 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 357,690 Item 6: 0 Item 7: 8,449,254 Item 8: 0 Item 9: 8,449,254 Item 11: 2.

GWPH / GW Pharmaceuticals Plc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 3 GW PHARMACEUTICALS PLC COMMON STOCK Cusip #G4210C104 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #G4210C104 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 357,690 Item 6: 0 Item 7: 8,449,254 Item 8: 0 Item 9: 8,449,254 Item 11: 2.

GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q1 2018 Results - Earnings Call Transcript

2018-02-06 seekingalpha
GW Pharmaceuticals plc (NASDAQ:GWPH) Q1 2018 Results Earnings Conference Call February 5, 2018 4:30 PM ET (2-0)


CUSIP: 36197T103